X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs NATCO PHARMA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD NATCO PHARMA WYETH LTD/
NATCO PHARMA
 
P/E (TTM) x 27.7 16.0 173.4% View Chart
P/BV x 5.3 17.2 31.0% View Chart
Dividend Yield % 1.3 0.7 191.8%  

Financials

 WYETH LTD   NATCO PHARMA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
NATCO PHARMA
Mar-14
WYETH LTD/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,044877 119.1%   
Low Rs818424 193.2%   
Sales per share (Unadj.) Rs298.6223.4 133.6%  
Earnings per share (Unadj.) Rs57.231.1 184.2%  
Cash flow per share (Unadj.) Rs58.440.3 145.0%  
Dividends per share (Unadj.) Rs17.005.00 340.0%  
Dividend yield (eoy) %1.80.8 237.4%  
Book value per share (Unadj.) Rs249.5219.5 113.7%  
Shares outstanding (eoy) m22.7233.07 68.7%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x3.12.9 107.2%   
Avg P/E ratio x16.320.9 77.7%  
P/CF ratio (eoy) x15.916.1 98.7%  
Price / Book Value ratio x3.73.0 126.0%  
Dividend payout %29.716.1 184.5%   
Avg Mkt Cap Rs m21,15721,504 98.4%   
No. of employees `0000.5NA-   
Total wages/salary Rs m4001,128 35.5%   
Avg. sales/employee Rs Th13,787.4NM-  
Avg. wages/employee Rs Th813.0NM-  
Avg. net profit/employee Rs Th2,643.3NM-  
INCOME DATA
Net Sales Rs m6,7837,389 91.8%  
Other income Rs m353167 211.0%   
Total revenues Rs m7,1367,556 94.4%   
Gross profit Rs m1,6171,793 90.2%  
Depreciation Rs m27304 8.7%   
Interest Rs m6366 1.5%   
Profit before tax Rs m1,9381,290 150.2%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m632309 204.8%   
Profit after tax Rs m1,3011,027 126.6%  
Gross profit margin %23.824.3 98.2%  
Effective tax rate %32.623.9 136.3%   
Net profit margin %19.213.9 137.9%  
BALANCE SHEET DATA
Current assets Rs m6,9843,681 189.7%   
Current liabilities Rs m2,0563,123 65.8%   
Net working cap to sales %72.67.6 961.0%  
Current ratio x3.41.2 288.2%  
Inventory Days Days9989 110.9%  
Debtors Days Days2459 40.8%  
Net fixed assets Rs m2447,685 3.2%   
Share capital Rs m227331 68.7%   
"Free" reserves Rs m5,4416,670 81.6%   
Net worth Rs m5,6687,259 78.1%   
Long term debt Rs m25955 2.6%   
Total assets Rs m7,90111,957 66.1%  
Interest coverage x353.34.5 7,813.3%   
Debt to equity ratio x00.1 3.4%  
Sales to assets ratio x0.90.6 138.9%   
Return on assets %16.511.7 141.8%  
Return on equity %22.914.2 162.1%  
Return on capital %34.020.7 164.3%  
Exports to sales %0.239.4 0.6%   
Imports to sales %36.35.7 637.6%   
Exports (fob) Rs m152,908 0.5%   
Imports (cif) Rs m2,465421 585.3%   
Fx inflow Rs m153,445 0.4%   
Fx outflow Rs m2,677703 380.9%   
Net fx Rs m-2,6622,743 -97.1%   
CASH FLOW
From Operations Rs m9231,440 64.1%  
From Investments Rs m317-1,089 -29.1%  
From Financial Activity Rs m-481-353 136.4%  
Net Cashflow Rs m759-1 -50,946.3%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 51.1 1.5 3,476.2%  
Indian inst/Mut Fund % 11.3 7.8 144.1%  
FIIs % 7.2 16.6 43.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 26.0 116.9%  
Shareholders   21,978 25,395 86.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   ALEMBIC PHARMA  STRIDES SHASUN LTD  FDC LTD.  ASTRAZENECA PHARMA  BIOCON LTD  

Compare WYETH LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 207 Points Higher; Healthcare Stocks Witness Buying(Closing)

Indian share markets continued to trade in the green during the closing hours of the trading session and ended the day on a positive note.

Related Views on News

NATCO PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 93.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 93.3% YoY). Sales on the other hand came in at Rs 5 bn (up 21.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 69.6% (Quarterly Result Update)

May 25, 2018 | Updated on May 25, 2018

For the quarter ended March 2018, NATCO PHARMA has posted a net profit of Rs 3 bn (up 69.6% YoY). Sales on the other hand came in at Rs 8 bn (up 32.9% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

The Biggest Mistake You Can Make in this Market (and 3 Stocks to Buy Now!)(Profit Hunter)

Aug 3, 2018

This price pattern can help you identify stocks on the verge of a turnaround.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

Is Franklin India Smaller Companies Fund Worth Your Money(Outside View)

Aug 2, 2018

Although positioned as a small cap fund, Franklin India Smaller Companies Fund has been investing a significant portion of its assets in mid-caps along with a nominal exposure to large caps.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WYETH LTD WITH

MARKET STATS